Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia.

MLA

Anker, Stefan D., et al. “Rationale and Design of Ferinject Assessment in Patients with IRon Deficiency and Chronic Heart Failure (FAIR-HF) Study: A Randomized, Placebo-Controlled Study of Intravenous Iron Supplementation in Patients with and without Anaemia.” European Journal of Heart Failure, vol. 11, no. 11, Nov. 2009, pp. 1084–91. EBSCOhost, https://doi.org/10.1093/eurjhf/hfp140.

APA

Anker, S. D., Colet, J. C., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Mori, C., von Eisenhart Rothe, B., Pocock, S., Poole-Wilson, P. A., & Ponikowski, P. (2009). Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. European Journal of Heart Failure, 11(11), 1084–1091. https://doi.org/10.1093/eurjhf/hfp140

Chicago

Anker, Stefan D, Josep Comin Colet, Gerasimos Filippatos, Ronnie Willenheimer, Kenneth Dickstein, Helmut Drexler, Thomas F Lüscher, et al. 2009. “Rationale and Design of Ferinject Assessment in Patients with IRon Deficiency and Chronic Heart Failure (FAIR-HF) Study: A Randomized, Placebo-Controlled Study of Intravenous Iron Supplementation in Patients with and without Anaemia.” European Journal of Heart Failure 11 (11): 1084–91. doi:10.1093/eurjhf/hfp140.